Accel-KKR-backed IntegriChain completed the acquisition of Cumberland's Life Science Division.

Accel-KKR-backed IntegriChain, a life sciences data and managed services company, completed the acquisition of the Life Science Division of Cumberland, a healthcare consulting and services firm. Financial terms were not disclosed. "This acquisition reinforces IntegriChain's market-leading position to help manufacturers drive access and maximize their commercialization success throughout the brand life cycle, from pre-launch through growth. We now deliver the industry's first and only data and managed services platform that unifies all of the critical business functions for commercialization and market access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider and pharmacy insights for our customers. As a result of this transaction, we are uniquely positioned to address critical therapy access challenges and ensure patients have access to specialty and precision medicines," Kevin Leininger, IntegriChain Co-Founder and CEO.